Aditxt, Inc. Payments for (Proceeds from) Productive Assets
Aditxt, Inc. (ADTX) reported Payments for (Proceeds from) Productive Assets of $5.05 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromProductiveAssets · last filed 2023-08-14
- Aditxt, Inc. payments for (proceeds from) productive assets for the quarter ending 2023-06-30 was $2.00, a 100.00% decline year-over-year.
- Aditxt, Inc. payments for (proceeds from) productive assets for the quarter ending 2023-03-31 was $5.05K, a 96.58% decline year-over-year.
- Aditxt, Inc. payments for (proceeds from) productive assets for the quarter ending 2022-12-31 was $88.82K, a 22.80% decline year-over-year.
- Aditxt, Inc. payments for (proceeds from) productive assets for the quarter ending 2022-09-30 was $4.18K, a 97.71% decline year-over-year.
- Aditxt, Inc. payments for (proceeds from) productive assets for fiscal 2022 was $367.08K, a 63.86% decline from fiscal 2021.
- Aditxt, Inc. payments for (proceeds from) productive assets for fiscal 2021 was $1.02M, a 495.30% increase from fiscal 2020.
- Aditxt, Inc. payments for (proceeds from) productive assets for fiscal 2020 was $170.63K.
| Period end | Payments for (Proceeds from) Productive Assets 3 month | Payments for (Proceeds from) Productive Assets 6 month | Payments for (Proceeds from) Productive Assets 9 month | Payments for (Proceeds from) Productive Assets 12 month |
|---|---|---|---|---|
| 2023-06-30 | $2.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $5.05K 10-Q · filed 2023-08-14 | $93.87K derived: sum of 3 quarters · filed 2023-08-14 | $98.06K derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $5.05K 10-Q · filed 2023-05-15 | $93.87K derived: sum of 2 quarters · filed 2023-05-15 | $98.06K derived: sum of 3 quarters · filed 2023-05-15 | $224.33K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | $88.82K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $93.01K derived: sum of 2 quarters · filed 2023-04-17 | $219.28K derived: sum of 3 quarters · filed 2023-08-14 | $367.08K 10-K · filed 2023-04-17 |
| 2022-09-30 | $4.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $130.45K derived: sum of 2 quarters · filed 2023-08-14 | $278.26K 10-Q · filed 2022-11-14 | $393.31K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | $126.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $274.07K 10-Q · filed 2023-08-14 | $389.13K derived: sum of 3 quarters · filed 2023-08-14 | $571.40K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $147.80K 10-Q · filed 2023-05-15 | $262.86K derived: sum of 2 quarters · filed 2023-05-15 | $445.13K derived: sum of 3 quarters · filed 2023-05-15 | $677.10K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $115.06K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $297.33K derived: sum of 2 quarters · filed 2023-04-17 | $529.30K derived: sum of 3 quarters · filed 2023-04-17 | $1.02M 10-K · filed 2023-04-17 |
| 2021-09-30 | $182.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $414.24K derived: sum of 2 quarters · filed 2022-11-14 | $900.69K 10-Q · filed 2022-11-14 | $910.79K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $231.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $718.42K 10-Q · filed 2022-08-15 | $728.52K derived: sum of 3 quarters · filed 2022-08-15 | |
| 2021-03-31 | $486.45K 10-Q · filed 2022-05-16 | $496.55K derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $10.10K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $170.63K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $160.53K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |